01 8NOVARTIS
01 89233956
01 8Blank
01 8Blank
01 82029-05-04
Patent Expiration Date : 2029-05-04
US Patent Number : 9233956
Drug Substance Claim :
Drug Product Claim :
Application Number : 202806
Patent Use Code : U-2032
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-05-04
Patent Expiration Date : 2029-05-04
US Patent Number : 9233956
Drug Substance Claim :
Drug Product Claim :
Application Number : 202806
Patent Use Code : U-2031
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-05-04
Patent Expiration Date : 2029-05-04
US Patent Number : 9233956
Drug Substance Claim :
Drug Product Claim :
Application Number : 202806
Patent Use Code : U-2296
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-05-04
Patent Expiration Date : 2029-05-04
US Patent Number : 9233956
Drug Substance Claim :
Drug Product Claim :
Application Number : 202806
Patent Use Code : U-2032
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-05-04
Patent Expiration Date : 2029-05-04
US Patent Number : 9233956
Drug Substance Claim :
Drug Product Claim :
Application Number : 202806
Patent Use Code : U-1811
Delist Requested :
Patent Use Description : TREATMENT OF PATIENTS ...
Patent Expiration Date : 2029-05-04
Patent Expiration Date : 2029-05-04
US Patent Number : 9233956
Drug Substance Claim :
Drug Product Claim :
Application Number : 202806
Patent Use Code : U-2031
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-05-04
Patent Expiration Date : 2029-05-04
US Patent Number : 9233956
Drug Substance Claim :
Drug Product Claim :
Application Number : 202806
Patent Use Code : U-2296
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-05-04
Patent Expiration Date : 2029-05-04
US Patent Number : 9233956
Drug Substance Claim :
Drug Product Claim :
Application Number : 202806
Patent Use Code : U-1811
Delist Requested :
Patent Use Description : TREATMENT OF PATIENTS ...
Patent Expiration Date : 2029-05-04
